Transfusion‐associated graft‐versus‐host disease
- 9 July 2008
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 95 (2), 85-93
- https://doi.org/10.1111/j.1423-0410.2008.01073.x
Abstract
Transfusion-associated graft-versus-host disease (TA-GvHD) is a rare complication of transfusion of cellular blood components producing a graft-versus-host clinical picture with concomitant bone marrow aplasia. The disease is fulminant and rapidly fatal in the majority of patients. TA-GvHD is caused by transfused blood-derived, alloreactive T lymphocytes that attack host tissue, including bone marrow with resultant bone marrow failure. Human leucocyte antigen similarity between the transfused lymphocytes and the host, often in conjunction with host immunosuppression, allows tolerance of the grafted lymphocytes to survive the host immunological response. Any blood component containing viable T lymphocytes can cause TA-GvHD, with fresher components more likely to have intact cells and, thus, able to cause disease. Treatment is generally not helpful, while prevention, usually via irradiation of blood components given to susceptible recipients, is the key to obviating TA-GvHD. Newer methods, such as pathogen inactivation, may play an important role in the future.Keywords
This publication has 63 references indexed in Scilit:
- Inactivation of Lymphocytes in Blood Products Using Riboflavin Photochemical Treatment with Visible LightPhotochemistry and Photobiology, 2008
- IL2 and TNFA Gene Polymorphisms and the Risk of Graft‐versus‐Host Disease after Allogeneic Haematopoietic Stem Cell TransplantationScandinavian Journal of Immunology, 2007
- Blood banking–induced alteration of red blood cell flow propertiesTransfusion, 2007
- The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host diseaseTransfusion, 2007
- Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host diseaseJournal of the American Academy of Dermatology, 2004
- Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantationLiver Transplantation, 2000
- Fludarabine treatment and transfusion-associated graft-versus-host diseaseThe Lancet, 1996
- Spontaneous resolution of transfusion‐associated graft‐versus‐host diseaseTransfusion, 1995
- Graft-versus-Host Disease Associated with Transfusion of Blood from Unrelated HLA-Homozygous DonorsNew England Journal of Medicine, 1993